InvestorsHub Logo
Post# of 251617
Next 10
Followers 4
Posts 1194
Boards Moderated 0
Alias Born 10/03/2015

Re: DewDiligence post# 195620

Sunday, 10/04/2015 6:04:49 PM

Sunday, October 04, 2015 6:04:49 PM

Post# of 251617
Given high SVR4 and SVR12 rates from ABBV P2, should FDA require GILD to do GS-9857+ GS-5816 studies? SOF may be required for TE and cirrhotics only.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.